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Abstract. 
This paper describes a method for the selective precipitation and purification of a monovalent 
protein (carbonic anhydrase is used as a demonstration) from cellular lysate using ammonium 
sulfate and oligovalent ligands. The oligovalent ligands induce the formation of protein-ligand 
aggregates, and at an appropriate concentration of dissolved ammonium sulfate, these complexes 
precipitate. The purification involves three steps: i) the removal of high-molecular weight 
impurities through the addition of ammonium sulfate to the crude cell lysate; ii) the introduction 
of an oligovalent ligand and the selective precipitation of the target protein-ligand aggregates 
from solution; and iii) the removal of the oligovalent ligand from the precipitate by dialysis to 
release the target protein. The increase of mass and volume of the proteins upon aggregate 
formation reduces their solubility, and results in the selective precipitation of these aggregates.  
We recovered human carbonic anhydrase, from crude cellular lysate, in 82% yield and 95% 
purity with a trivalent benzene sulfonamide ligand. This method provides a chromatography-free 
strategy of purifying monovalent proteins—for which appropriate oligovalent ligands can be 
synthesized—and combines the selectivity of affinity-based purification with the convenience of 
salt-induced precipitation. 
 3 
Introduction.  
The solubility of a protein in an aqueous solution depends on the complex interaction of four 
parameters: i) its physical properties (shape, flexibility, molecular weight, and isoelectric point), 
ii) the distribution of the hydrophobic, hydrophilic, and charged groups on its surface, iii) the 
temperature and pH of the solution, and iv) the composition and concentration of various co-
solutes.
1 Current theory suggests the relative importance of each of these parameters in 
determining the solubility of a protein. While the theory is unable to predict protein solubility in 
an experimental context,
2 the purification of proteins by precipitation is often a very convenient 
procedure, despite the fact that it remains a largely empirical process.
3,4 
This paper describes a method for the precipitation of (and thus, the purification of) 
monomeric proteins, selectively, with a combination of oligovalent ligands and ammonium 
sulfate. The interaction of multiple ligands—where a ligand is defined as a small molecule that 
specifically binds to a protein or receptor of interest—attached to a single entity with multiple 
receptors on another entity is common in biology and, especially, immunology: a multivalent 
interaction. We define an oligovalent ligand, in the context of this work, as a single organic 
molecular scaffold containing less than ten ligands, of the same chemical structure, that target a 
single protein receptor. 
The formation of a protein-ligand aggregate (i.e., multiple proteins interacting with a single 
oligovalent ligand) increases the molecular mass and volume of the protein of interest and 
decreases the solubility of the aggregate; this increase allows the aggregate to be removed from 
solution as a precipitate (Scheme 1). Modulating the solubility of a given protein—by 
introducing oligovalent ligands that form protein-ligand aggregates of known stoichiometries—4 
provides a strategy for purifying proteins, for which appropriate ligands are available or can be 
synthesized without the need of chromatographic methods.  
The salt-induced precipitation of proteins is a simple, rapid, and inexpensive method of 
purification.
3-5 Many proteins have similar solubility in aqueous solutions of a salt, however, and 
precipitate simultaneously; salt-induced precipitation of proteins is, for this reason, generally the 
first step in a series of steps of purification. The lack of selective and simple protein purification 
methods has led to the development of chromatographic techniques (e.g., ion exchange, size-
exclusion, and affinity).
3-5 Affinity chromatography is a selective method for purifying proteins 
when a tight-binding (Kd < 100 M) ligand for the protein is known; affinity chromatography, 
however, i) is time-consuming, ii) requires large volumes of eluent to remove the protein from 
the solid support (thus diluting the sample), iii) requires pumps and fraction collectors (as well as 
supporting auxiliary equipment), and iv) is limited in throughput. An ideal method of 
purification would have the selectivity of affinity chromatography, but the speed, low cost, and 
throughput of salt-induced precipitation.  
We and others have developed several methods that aim to combine the convenience of salt-
induced precipitation with the selectivity of affinity chromatography. Bilgiçer et al. used a 
combination of bivalent ligands and ammonium sulfate (AMS) precipitation to purify antibodies 
from ascites fluid with yields of > 80% and with > 95 % purity.
6  
Another method of purification—based on altering the solubility of proteins—is ―affinity 
precipitation‖,
5,7-9 which relies on multivalent ligands to modify the solubility of proteins, but 
does not involve the addition of AMS. Affinity precipitation was developed initially for the 
selective precipitation of multimeric proteins with bivalent ligands; the ligands cause 
precipitation by inducing the formation of an insoluble, cross-linked, macromolecular network of 5 
the protein complex.
7 This strategy was utilized to purify monomeric proteins with polymeric 
scaffolds that contain both an affinity ligand and another functional group that controls the 
solubility of the polymer.
8,9 The solubility of the polymeric ligand can be regulated, typically, by 
changes in pH, temperature, or ionic strength of the medium.
10 This method has three limitations: 
i) the ligands immobilized on a polymeric scaffold tend to bind less strongly than their 
monovalent analogs; ii) the resolubilization of the protein in the presence of the polymer is slow; 
and iii) the cross-linked aggregates of proteins and polymers can trap impurities during 
precipitation. 
Selective Isolation of Protein by Combining Oligovalent Aggregation with Ammonium 
Sulfate (AMS) Precipitation. This paper describes a method that combines the selectivity of 
affinity-based methods with the convenience of AMS precipitation. We use non-polymeric, 
oligovalent ligands (with molecular weights < 5000 Da) to induce the aggregation of monomeric 
proteins—containing a single ligand binding site—by selectively binding the protein to the 
oligovalent small molecules. The formation of a higher molecular-weight aggregate, at a 
concentration of ammonium sulfate that is just below that required to precipitate the monomeric 
protein, selectively converts the targeted protein from a soluble monomer to an insoluble 
aggregate.  
The procedure has three steps (Figure 1): i) impurities that are higher in molecular weight 
than the target protein are removed by precipitation with AMS (the concentration of AMS is 
such that the protein of interest does not precipitate); ii) the target protein is caused to aggregate 
and precipitate by adding an oligovalent ligand; the precipitate is isolated and redissolved in 
solution by the addition of buffer that does not contain AMS; iii) the ligand is removed by 
dialysis.  6 
This technique of purifying proteins has five useful characteristics: i) it is selective; ii) it can 
be adapted easily to improve the efficiency of existing processes that rely on salt-induced 
precipitation; iii) it is rapid; iv) it should scale easily to large volumes (> 1L); and v) it both 
purifies and concentrates the target protein. This method also has limitations: i) it requires both a 
small-molecule ligand that binds tightly (Kd < 100 M) to the target protein, and a practical 
synthetic route to prepare the oligovalent ligand; ii) it requires separating the protein from the 
ligand after precipitation. In general, i) is the most constraining of these limitations. 
 
Experimental Design and Rationale. 
Choice of Protein-Ligand System. We chose carbonic anhydrase (CA, E.C. 4.2.1.1) as 
our model system as the binding of benzene sulfonamides to CA is conserved, has been 
extensively studied, and is well characterized with X-ray crystallography. There are numerous 
benzene sulfonamides that are available commercially, with a range of binding affinities, that are 
attached easily to oligovalent scaffolds.
11,12 We have reviewed the relevant characteristics of CA 
as a model system for biophysical studies in great depth,
11 and have extensive experience 
studying the interaction of benzene sulfonamide ligands with CA.  
In this study, we precipitated bovine carbonic anhydrase II (BCA), selectively, from 
buffered solutions with oligovalent benzene sulfonamide ligands (monovalent to trivalent). We 
used pure BCA as a model system to examine the relationships between the relevant 
experimental parameters (e.g., dissociation (Kd) constants of the ligand, the stoichiometry of the 
aggregate, and the concentration of AMS). We also purified human carbonic anhydrase II 
(HCA), selectively, from crude E. coli lysate with a trivalent benzene sulfonamide ligand. 7 
Choice of Salt. We precipitate aggregates of CA and an oligovalent benzene sulfonamide 
ligand in the presence of AMS. This salt is commonly used in preparative protein purification
3-5 
as it is commercially available in high purity (> 99.9 %) and low cost (< $0.01 per gram), is 
soluble in water at concentrations up to 4 M, possesses a low enthalpy of dissolution, and is non-
buffering and non-denaturing.  
  Oligovalent Ligand Scaffolds. We linked the benzene sulfonamide molecules with units 
of oligoethylene glycol (OEG) because of their flexibility and relative inertness. We synthesized 
the oligovalent ligands (Figure 2) from commercially available starting materials, by linking the 
nucleophilic amine of the OEG scaffold with the N-hydroxysuccinimide (NHS)-activated 4-
carboxybenzenesulfonamide (unless otherwise noted) using standard condensation chemistries.
13 
We also synthesized a monovalent control (Figure 2) to show that the presence of the 
oligoethylene glycol tail does not inhibit protein-ligand binding and, in turn, interfere with 
protein precipitation. The Supporting Information outlines the details of the synthetic procedures 
used to make each benzene sulfonamide ligand, as well as their corresponding 
1H NMR and 
mass spectra. 
 
Results and Discussion. 
Characterization of the Binding of the Oligovalent Ligands to CA. We measured the 
monovalent dissociation constant (Kd) of each of the benzene sulfonamide scaffolds from BCA 
with a fluorescence-based competition assay.
14-16 To determine Kd, we used a model that 
assumed independent and equivalent binding of each benzene sulfonamide to BCA. This model 
yielded the following monovalent dissociation constants for the benzene sulfonamideswithin 8 
these ligands, from BCA: Kd(monovalent, L1) = 0.5 0.1 M, Kd(bivalent, L2) = 0.4  0.1 M, 
Kd(trivalent, L3) = 0.6  0.6 M. 
Effect of Oligovalent Ligands on the Solubility of Proteins in Aqueous Solutions of AMS. 
We precipitated BCA—in a buffered solution containing ammonium sulfate, ranging from 1.5 – 
3.6 M—in the presence of no ligand, L1, L2, and L3 (Figure 3). In these experiments, we 
combined BCA, AMS, and the ligand in 20 mM NaH2PO4 buffer, pH = 7.5 (see Supporting 
Information for details of this experiment), vortexed this mixture for ~10 s to promote rapid 
mixing, gently agitated the mixture using a rocker-type shaker for 4 hours at 4 °C to allow 
sufficient time for precipitation to occur,
17 and then centrifuged the mixture to separate the 
precipitate from the supernatant. We resuspended the pellet in 20 mM NaH2PO4 buffer (pH = 
7.5) and determined the concentration of protein in the pellet with UV-VIS absorption 
measurements. Figure 3 reports the fraction of protein recovered in the pellet in relation to the 
total amount of protein. 
Figure 3 illustrates the ligand-dependent solubility for BCA in AMS; the solubility of 
BCA decreases as the size of the putative oligovalent aggregate increases for a given 
concentration of AMS. The horizontal dashed line in Figure 3 corresponds to the concentration 
of AMS required to precipitate 50% of the BCA present in solution. The vertical dashed line 
shows that no BCA precipitates in the absence of ligand at a concentration of 2.5 M, whereas 
over 70% of the BCA precipitates in the presence of the bi- and tri-valent ligand. Together, these 
results serve as a basis for the expected selectivity, and thus selective precipitation, for a protein 
in a complex mixture. 
Experimental Parameters for Protein Precipitation. The choice of experimental 
parameters—the type of buffer, the pH of the AMS solution, the length of OEG linker, the Kd of 9 
the ligand, and the concentration of protein in solution—may all affect the efficiency of protein 
precipitation with oligovalent ligands from a solution of AMS.  
Linker length: The distance between binding sites, in an oligovalent ligand, must 
sufficiently separate the proteins of interest to enable the oligovalent aggregate to form. We 
estimated—based on X-ray crystallographic structural information of CA—that a bivalent ligand 
must separate the two binding sites of CA by a total distance of 3 nm, and hypothesized that 
combinations of ligands and linkers that fall short of this 3 nm requirement would fail to promote 
the precipitation of CA from an AMS solution. We synthesized several analogs of the L2 ligand 
(Figure 2) with linkers of various oligoethylene glycol (OEG) units: OEG 1, OEG 2, OEG 10, 
and OEG 19. We found that L2 connected by OEG 19 (~5.5 nm between each ligand) was the 
most efficient at reducing the solubility of BCA in AMS, and that analogs having shorter linkers 
of OEG were less effective, and less reproducible.
18  
Protein concentration and Kd: We examined the relationship between the Kd of the ligand 
and the concentration of protein. We expected that the ligand would determine the solubility of 
the protein if the protein-ligand aggregate were thermodynamically stable (e.g., had low values 
of Kd and Kd), as the formation of a precipitate drives the equilibrium toward the formation of 
the bivalent aggregate (Scheme 1). We previously proposed an analytical model to predict the 
concentration of bivalent ligand needed to form the maximum amount of the protein-ligand 
complex in a solution containing the monomeric, monovalent protein.
19 Eq. 1 describes the 
optimum concentration of bivalent ligand needed to maximize the formation of a protein-ligand 
complex
19 between L2 (Kd = 0.4  0.1M) and 20M of BCA:  

L2  
0,max 
Kd L2  
2

BCA  0
2
10.2 M.      (Eq. 1) 10 
We designed two experiments to compare the concentration of L2 needed (as determined 
experimentally) with the values predicted by Eq. 1: (i) we examined aggregate precipitation at 
several concentrations of BCA (2 – 20 M) with a fixed concentration (40 M) of L2; (ii) we 
synthesized a chemical analog of L2 (L2-weak, Figure 2) with a reduced Kd: Kd(L2) = 0.4  0.1 M 
vs. Kd(L2-weak) = 10.8  0.7 M.  
The precipitation of BCA with L2 was most effective for the highest concentration of 
BCA (20 M): 4 equivalents of L2 per mole of BCA. This concentration of ligand exceeds the 
value predicted by Eq. 1 by a factor of 4. We attribute the disparity in the observed and predicted 
optimum concentrations of L2 to differences in the experimental conditions and the conditions 
assumed in the model.
19 Eq. 1 applies to binding processes under equilibrium conditions where 
the individual binding partners and their binding complexes are dispersed uniformly in solution. 
The system we present here is not under equilibrium conditions, and thus we do not expect the 
equilibrium model described by Mack et al.
19 to predict the exact concentration of ligand needed, 
as the: i) the binding occurs in a highly concentrated AMS solution that promotes the 
aggregation and precipitation of the protein-ligand complexes from solution; ii) the kinetic 
process of precipitation alters the concentration of protein, ligand, and their complex in solution 
during the course of the experiment. We see this model, however, as a means of predicting a 
starting point for semi-empirical experimental optimization. 
L2-weak was less effective than L2 (Figure 2) at promoting the precipitation of 20  
BCA from a solution of AMS. Less than 20% of the BCA (20 M) precipitated in the presence 
of a large excess of L2-weak ligand (e.g., 200 , 20 equivalents of ligands per mole of BCA), a 
result that agrees, qualitatively, with Eq. 1: the lower the value of Kd for a ligand, the lower the 
concentration of ligand is needed to aggregate and precipitate the protein.  11 
Solution pH and buffer conditions: We examined the effect of the buffer composition and 
pH on protein precipitation. We anticipated that neither would influence precipitation; the excess 
of AMS dominates the ionic strength of the aqueous solutions used for precipitation. We 
confirmed this hypothesis experimentally, and conclude that both the type of salt used to buffer 
the AMS solution, and the pH of solution (6.0 – 7.5) has negligible effects on the efficiency of 
this precipitation process.
20 
Selective Precipitation of CA from Cellular Lysate. We selectively precipitated human CA 
(HCA) from a complex mixture of other proteins (i.e., crude lysate) with a trivalent ligand. First, 
we added a known amount of HCA to E. coli lysate (1 mg / 10 mL, 3.4 M); this experiment 
allowed us to quantify the efficiency of the precipitation process. In a separate experiment, we 
purified HCA from crude E. coli lysate in which the protein was over-expressed.
11, 21 The 
selective precipitation of over-expressed protein from cellular lysate provides a means of 
purifying protein produced on a small scale without the need of chromatography.  
To determine the optimal salt concentration required to precipitate the majority of the 
proteins in the lysate while retaining HCA in the supernatant, we incubated E. coli lysate—
containing a known amount of HCA—in different concentrations of AMS (1.6 – 3.2 M, final 
concentration in 1.0 mL samples). We resuspended the precipitate in an equal volume of 
phosphate buffered saline (1X PBS), determined the amount of protein contained in the 
supernatant and in the precipitate with SDS-PAGE, and quantified the total protein concentration 
for each supernatant and precipitate sample with a standard Bradford assay.
22 The majority of the 
proteins from the cellular lysate samples were precipitated (62% of the total proteins, as 
determined with a standard Bradford assay) in 2.4 M AMS, while greater than 70% of the HCA 
was retained in solution at that concentration of AMS, as estimated by SDS PAGE. 12 
To determine the optimum ligand concentration needed to precipitate a known amount of 
HCA in cellular lysate (100 g of HCA total; 3.4 M), we added known amounts of trivalent 
ligand (0, 5, 12.5 and 25 M) to a 1.0 mL suspension of E. coli supernatant in 2.4 M AMS, and 
rocked the mixture at 4 °C for 4 hours.
17 The precipitate contained a small amount of unwanted 
proteins, which we removed by washing and recentrifuging the pellet: the pellet was resuspended 
in 100 L of 2.4 M AMS, centrifuged, and the supernatant removed. The pellet, precipitated with 
the trivalent ligand, contained 82 ± 2  of the HCA (n = 7 measurements) in the cellular lysate, 
and was >95% pure, as judged by gel electrophoresis. A fraction of the total HCA, 11 ± 4  (n = 
7 measurements) was precipitated in the absence of ligand.  
We also precipitated a sample of over-expressed HCA from crude E. coli lysate.
11, 21 Figure 
4 summarizes the results of a representative precipitation experiment, as analyzed with SDS 
PAGE, in which 50 M of the trivalent ligand was added to 1.0 mL of E. coli crude lysate, the 
sample was incubated at 4 
oC for four hours, and the protein-ligand aggregate precipitated. In 
this case, addition of trivalent ligand precipitated HCA that was ~90% pure, and a single wash of 
the precipitated protein provided HCA that was >95% pure as determined via Bradford assay. 
Formation of an oligomeric aggregate between HCA and an oligovalent ligand is necessary 
for selective precipitation. We performed an experiment analogous to that presented in Figure 3 
and precipitated a known amount of HCA (100 g; 3.4 M)—in the presence of L1, L2, and L3—
from 2.5 mL of crude E. coli lysate. Each reaction contained an equivalent amount of benzene 
sulfonamide groups available for binding to HCA (i.e., 75 M L1, 37.5 M L2, and 25 M L3). A 
control experiment was also performed in which HCA was precipitated in the absence of ligand. 
We washed the precipitated pellets containing aggregates of protein and ligand to remove non-
specifically bound proteins and then analyzed the precipitates qualitatively with SDS PAGE, and 13 
quantitatively with a Bradford assay: L1 ~ 15 ± 6 , L2 = 55 ± 3 , L3 = 82 ± 2  of the total 
HCA contained in each lysate sample. These data are consistent with those obtained for the BCA 
samples (Figure 3); the amount of protein recovered increased with the size of the protein-ligand 
aggregate. 
A small number of unwanted proteins were present in both the bi- and trivalent ligand 
precipitates, but were successfully removed by a single washing step. The total protein content of 
each pellet was determined directly after precipitation, after a single washing step, and after four 
washing steps. The trivalent pellet was ~90 pure HCA after precipitation, before any wash 
steps. The amount of HCA present in the pellet was not statistically different after one and four 
washes; only a single band was present in the SDS PAGE.  
The monovalent ligand precipitated 25 ± 4 of the total protein contained in the E. coli 
lysate, while 11 ± 4  of the protein was precipitated in the absence of ligand. L1 should not 
induce the precipitation of HCA from solution, as the mass and volume of the protein-ligand 
aggregate has not changed significantly. The majority of the precipitated proteins for L1, and for 
experiments containing no added ligand were not HCA, as determined with SDS PAGE. We 
repeatedly washed the L1 precipitate several times with 1X PBS to remove the non-specifically 
adsorbed proteins; the pellet contained ~ 15 ± 6  of the HCA after four washes. This value is a 
relative estimate, as bands from protein impurities were still evident in the SDS PAGE.  
Considerations for the Design of an Oligovalent Ligand. The design of the oligovalent ligand 
determines its compatibility with the strategy—the selective precipitation and purification with 
an oligovalent ligand, via the formation of an aggregate of the protein and the ligand—presented 
here. The ligand also determines the efficiency of the formation of the stable protein-ligand 
aggregate that precipitates in the presence of AMS. There are three important parameters that 14 
must be considered before designing and synthesizing the oligovalent ligand: i) the Kd of the 
ligand, ii) the number of ligands attached to a central scaffold (i.e., the valency of the ligand), 
and iii) the length of the linker that connects the individual ligands.  
The value of Kd of the ligand—the strength the protein-ligand association—determines the 
concentration of ligand needed to precipitate an aggregate composed of the monovalent protein 
and the ligand from the AMS solution. An increase in the Kd of the bivalent ligand resulted in a 
reduced amount of BCA precipitating from a 2.36 M AMS solution: 60% of the BCA in solution 
precipitated in the presence of 40 M of the L2 ligand (Kd = 0.4 M) while 20% of the BCA in 
solution precipitated in the presence of 200 M of L2-weak (Kd = 10 M). 
The amount of precipitated protein increases with the valency of the oligovalent ligand; the 
number of ligands present corresponds to an increased mass and volume of the protein-ligand 
aggregate. The trend observed for mono-, bi-, and trivalent ligands is a decrease in the solubility 
of the aggregate with an increase in valency of the ligand. The synthesis of oligovalent ligands 
with higher valency should further decrease the solubility of the protein-ligand aggregate, 
thereby, in principle, increasing the amount of precipitated protein.  
Lengthening the linker that connects the individual benzene sulfonamide molecules to the 
oligovalent ligand, increased the efficiency of BCA precipitation. For our purification strategy to 
be successful, the length of the linker must be long enough to span the distance between the 
binding sites of two protein molecules without enthalpic penalty from steric interactions between 
atoms of the proteins. This distance, of course, will depend on the structure and size of the 
protein of interest. 
Conclusions 15 
This paper describes the combination of oligovalent ligands and AMS for the selective 
precipitation and purification of a model protein, carbonic anhydrase, from cellular lysate. An 
optimized procedure produced HCA in 82 % yield, and approximately 95% purity.  
This method combines the ease and speed of salt-induced precipitation with the selectivity of 
affinity chromatography and offers a rapid and selective approach to purifying monomeric 
proteins that have known ligands. This method has five useful characteristics for protein 
purification: i) it is rapid (formation of precipitate occurs within minutes); ii) it is selective for 
target protein, and ensures that the purified protein contains intact active site; iii) it is mild and 
non-denaturing (AMS promotes folding of proteins and protects proteins from degradation by 
proteases); iv) it concentrates the protein during purification; v) it should scale easily to large 
volumes. This method has also two limitations: i) it requires a ligand (with a sufficiently low Kd, 
< 100 M) that binds to the protein; ii) it involves the separation of the ligand from the protein 
after purification. 
We believe this method may be particularly attractive for: i) improving the efficiency of 
existing purification processes that rely on salt-induced precipitation; ii) streamlining purification 
schemes that involve a series of chromatographic and non-chromatographic steps; iii) replacing 
affinity chromatography to reduce the cost, time, and volume of eluent in purification. This 
method provides a simple means that can be applied to the routine purification of proteins of 
interest, at natively- and over-expressed concentrations, from cellular lysate.  
 
 
 
 16 
Supporting Information Available.  
  General methods; detailed synthetic procedures and 1H NMR and mass spectra; 
additional figures (Figures S1 – S8). This material is available free of charge via Internet at 
http://pubs.acs.org. 
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Captions: 
 
Scheme 1. The selective precipitation proteins with oligovalent ligands. The dissociation 
constant (Kd) dictates the formation and stability of a bivalent protein-ligand aggregate, in which 
a bivalent ligand of known binding affinity is introduced into a solution containing the protein. 
The Kd of the monovalent and bivalent complex is assumed to be the same in this system. The 
increase in mass (and volume) of the aggregates, in solution, results in the decreased solubility of 
the protein(s), and promote precipitation. 
 
Figure 1.  General strategy for purifying proteins using oligovalent ligands.  The ligands induce 
aggregation of monovalent proteins and reduce their solubility in aqueous solutions containing 
dissolved ammonium sulfate. 
 
Figure 2.  Structures of ligands used for selective precipitation of CA from aqueous solutions of 
ammonium sulfate. 
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Figure 3. The precipitation of BCA from AMS in Tris-Gly buffer (pH = 7.5, 4 °C) in the 
presence of L1, L2, L3 and no ligand. The concentration of each component is: [BCA]0 = 15 μM, 
[L1]0 = 90 μM, [L2]0 = 45 μM, and [L3]0 = 30 μM.  The ratio of ligand to protein was optimized 
empirically to maximize the yield of precipitate. The error bars represent the deviation from 
three independent measurements; for clarity, we have only included the best fits (solid lines) for 
the experiments with no added ligand, and with L3.  The horizontal dashed line represents the 
point at which fifty percent of the BCA was precipitated from solution and the vertical dashed 
line corresponds to 2.5 M AMS. 
 
Figure 4.  Precipitation of HCA with AMS and L3 from a cellular lysate.  Images of SDS PAGE 
lanes showing (i) the total number of proteins remaining in 2.4 M AMS after centrifugation, (ii) 
the total number of proteins precipitated after the addition of 50 M L3 ligand, (iii) the remaining 
HCA after the pellet of precipitated protein obtained from (ii) was washed with 1X PBS solution. 
The black box marks the bands corresponding to HCA. 
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